شماره ركورد
422131
عنوان مقاله
تعيين اثرات انالاپريل و لوزارتان بر روي آسيب DNA سلولي در بيماران پيوند كليه اي با پلي مورفيسم هاي سيستم رنين - آنژيوتانسين
عنوان به زبان ديگر
The Effects of Enalapril and Losartan on DNA Damage in Renal
Transplant Recipients with Regarding to Renin-Angiotensin
System Polymorphisms
پديد آورندگان
ويسي، پگاه نويسنده دانشگاه علوم پزشكي تبريز VEISI, P , قرباني حق جو، امير نويسنده دانشكده پيراپزشكي- مركز تحقيقات بيوتكنولوژي،دانشگاه علوم پزشكي تبريز Ghorbani Haghjoo, A. , ارگاني، حسن نويسنده دانشكده پزشكي- دانشگاه علوم پزشكي شهيد بهشتي تهران ARGANI, H , آقايي شهسواري، محمد نويسنده دانشگاه علوم پزشكي تبريز AGHAEISHAHSAVARI, M , نوروزيان اول، مسعود نويسنده دانشگاه علوم پزشكي تبريز NOROOZIANAVVAL , M , رشتچي زاده، نادره نويسنده دانشگاه علوم پزشكي تبريز Rashtchizadeh , N , صفا، جاويد نويسنده دانشكده پزشكي- دانشگاه پزشكي تبريز SAFA, J , مسگري، مهران نويسنده مركز تحقيقات كاربردي دارويي تبريز Mesgari , M
اطلاعات موجودي
فصلنامه سال 1387
رتبه نشريه
علمي پژوهشي
تعداد صفحه
8
از صفحه
133
تا صفحه
140
كليدواژه
انالاپريل , آسيب DNA سلولي , پلي مورفيسم هاي سيستم رنين - آنژيوتانسين , پيوند كليه , لوزارتان
چكيده لاتين
Background and Objectives: Oxidative injury of DNA and lipids may be supervised by
renin-angiotensin system (RAS). In the study the effect of losartan (L) and/or enalapril (E) on
reduction of DNA damage was evaluated regarding to renin-angiotensin system polymorphisms.
Materials and Methods: After determination of genotypes of the angiotensin converting
enzyme (ACE I/D), angiotensinogen (AGT M235T) and angiotensin II type 1 receptor (ATR1
A1166C) by polymerase chain reaction, 64 renal transplant recipients randomly allocated to one
of the four groups: first (13 patients) and second (20 patients) groups were treated with E (E+:
10mg/d) and L (L+: 50 mg/d) alone respectively. The third group (13 patients) as positive
control received E+L (E+L+: 10mg/d + 50 mg/d) and the forth group (22 cases) received no
medication as negative control (E-L-). The subjects were followed for 8 weeks. After 2 weeks
washout period, E group changed to L and vice versa as cross-over design. They were followed
for another 8 weeks. Before and after 2 months treatment, we checked the serum 8-OHdG and
Malondialdehyde (MDA) as biomarkers of DNA damage and lipid peroxidation respectively.
Results: Serum 8-OHdG levels were significantly decreased in the E+L+ and L+ groups
(6.07±1.1 ng/ml to 3.6±0.58 ng/ml, P=0.000; 5.30±0.86 ng/ml to 3.6±0.47 ng/ml, P=0.001
respectively). 8-OHdG level was not decreased significantly in E+ group (6±1.19 ng/ml to
4.7±1.39 ng/ml, P=0.07) and E-L- group (5.30±0.84 to 5.6±0.88 ng/ml, P=0.11). Patients with
DD genotype of ACE and CC genotype of ATR1 had higher serum 8-OHdG levels at the
basline (P=0.02, P=0.002 respectively). Only TT genotype of AGT had the most antioxidative
role regarding to kind of above treatment regimens (P=0.01). We found a remarkable correlation
between MDA and DNA damage levels before and after intervention (r=0.48, P=0.000; r=0.35,
P=0.006).
Conclusion: Although serum 8-OHdG level is higher in DD and CC genotypes of ACE and
ATR1 polymorphisms; the protective effects of L+ and E+L+ on DNA breaks are surprising
regarding to the RAS genotypes. TT genotype of AGT had important role in prevention of DNA
break regarding to kind of treatment
سال انتشار
1387
عنوان نشريه
مجله پزشكي- دانشگاه علوم پزشكي و خدمات بهداشتي درماني تبريز
عنوان نشريه
مجله پزشكي- دانشگاه علوم پزشكي و خدمات بهداشتي درماني تبريز
اطلاعات موجودي
فصلنامه با شماره پیاپی سال 1387
كلمات كليدي
#تست#آزمون###امتحان
لينک به اين مدرک